logo
Plus   Neg
Share
Email

Roche 9-month Sales Up 10%; Raises FY19 Outlook - Quick Facts

Roche Holding AG (RHHBY) reported that Group sales increased 10 percent at constant exchange rates and 9 percent in Swiss francs, in the first nine months of 2019, due to new products. Pharmaceuticals Division sales were up 12 percent, driven by high demand for recently launched medicines, mainly Ocrevus, Hemlibra, Tecentriq and Perjeta. Diagnostics Division sales grow 4 percent, primarily due to its immunodiagnostic testing portfolio.

In the first nine months of 2019, Group sales rose 10 percent to 46.1 billion Swiss francs. Sales in the Pharmaceuticals Division increased 12 percent to 36.6 billion francs. Diagnostics Division sales increased 4 percent to 9.5 billion francs.

Based on the strong demand for new medicines and continued progress of product pipeline, Roche now expects sales to grow in the high-single digit range, at constant exchange rates, for 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Motors Co. (GM) is hiring for new workforce, after cutting about some 4,000 salaried employees early this year. According to Detroit Free Press, the auto giant is hiring for a new workforce as the company invests more money to develop electric and self-driving vehicles. Earlier this year,... Australia's Federal Court has ruled in favor of more than 1,000 women in a landmark class-action lawsuit against Johnson & Johnson after they suffered severe pain and complications from the healthcare giant's pelvic mesh implants. Johnson & Johnson and its subsidiary Ethicon were accused of hiding the risks of its pelvic mesh products. SpaceX's Starship rocket prototype was damaged while undergoing pressurization testing on Wednesday evening. Video from the vicinity of SpaceX's Boca Chica test facility in Texas showed white plumes erupt from the top part of the Starship Mark 1 vehicle while it was undergoing a pressurization test. The eruption blew off the upper bulkhead high into the air.
Follow RTT
>